Study: NCT05820633

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Report and compare changes in a non-inferiority analysis of the International Prostate Symptom Score (I-PSS)
Description: Assess early and late genito-urinary (GU) toxicities induced assessed via the International Prostate Symptom Score (I-PSS) in the experimental UHF group has compared in a non-inferiority analysis to those of patients who received a standard treatment (control group).

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Report and compare changes in a non-inferiority analysis of the International Prostate Symptom Score (I-PSS)
Description: Assess early and late genito-urinary (GU) toxicities induced assessed via the International Prostate Symptom Score (I-PSS) in the experimental UHF group has compared in a non-inferiority analysis to those of patients who received a standard treatment (control group).

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Report and compare changes in a non-inferiority analysis of the expanded prostate cancer index composite (EPIC-26):
Description: Assess early and late genito-urinary (GU) and gastro-intestinal (GI) toxicities induced and quality of life assessed via expanded prostate cancer index composite (EPIC-26) in the experimental UHF group has compared in a non-inferiority analysis to those of patients who received a standard treatment (control group).

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Report and compare changes in a non-inferiority analysis of the expanded prostate cancer index composite (EPIC-26):
Description: Assess early and late genito-urinary (GU) and gastro-intestinal (GI) toxicities induced and quality of life assessed via expanded prostate cancer index composite (EPIC-26) in the experimental UHF group has compared in a non-inferiority analysis to those of patients who received a standard treatment (control group).

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Report and compare changes in a non-inferiority analysis of the Sexual Health Inventory for Men (SHIM)
Description: Assess early and late sexual health in the experimental UHF group has compared in a non-inferiority analysis to those of patients who received a standard treatment (control group).

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Report and compare changes in a non-inferiority analysis of the Sexual Health Inventory for Men (SHIM)
Description: Assess early and late sexual health in the experimental UHF group has compared in a non-inferiority analysis to those of patients who received a standard treatment (control group).

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Report and compare changes in a non-inferiority analysis of the toxicities reported according to the Common Terminology Criteria for Adverse Events (CTCAE)
Description: Assess early and late toxicities reported according to the Common Terminology Criteria for Adverse Events (CTCAE) in the experimental UHF group has compared in a non-inferiority analysis to those of patients who received a standard treatment (control group).

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Report and compare changes in a non-inferiority analysis of the toxicities reported according to the Common Terminology Criteria for Adverse Events (CTCAE)
Description: Assess early and late toxicities reported according to the Common Terminology Criteria for Adverse Events (CTCAE) in the experimental UHF group has compared in a non-inferiority analysis to those of patients who received a standard treatment (control group).

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Report and compare the biochemical disease free survival (bDFS)
Description: Assess the 5 and 10 years biochemical disease-free survival (bDFS) in the UHF group and compare them for non-inferiority to those of the control group.

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Report and compare the biochemical disease free survival (bDFS)
Description: Assess the 5 and 10 years biochemical disease-free survival (bDFS) in the UHF group and compare them for non-inferiority to those of the control group.

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Report and compare the disease free survival (DFS)
Description: Assess the 5 and 10 years disease-free survival (DFS) in the UHF group and compare them for non-inferiority to those of the control group.

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Report and compare the disease free survival (DFS)
Description: Assess the 5 and 10 years disease-free survival (DFS) in the UHF group and compare them for non-inferiority to those of the control group.

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Report and compare the metastase free survival (MFS)
Description: Assess the 5 and 10 years metastasis-free survival (MFS) in the UHF group and compare them for non-inferiority to those of the control group.

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Report and compare the metastase free survival (MFS)
Description: Assess the 5 and 10 years metastasis-free survival (MFS) in the UHF group and compare them for non-inferiority to those of the control group.

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Report and compare the overall survival (OS)
Description: Assess the 5 and 10 years overall survival (OS) in the UHF group and compare them for non-inferiority to those of the control group.

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Report and compare the overall survival (OS)
Description: Assess the 5 and 10 years overall survival (OS) in the UHF group and compare them for non-inferiority to those of the control group.